EFFECT OF 4% ARTICAINE INFILTRATION VERSUS 2% LIDOCAINE NERVE BLOCK AFTER PREMEDICATION BY IBUPROFEN ON ANESTHETIC EFFICACY IN ENDODONTIC TREATMENT OF ACUTE IRREVERSIBLE PULPITIS: A RANDOMIZED CLINICAL TRIAL (PART I)

Anesthetic efficacy of 2% mepivacaine versus 4% articaine for inferior alveolar nerve blocks in patients with symptomatic irreversible pulpitis in mandibular molars: A randomized clinical trial (Part 1)

Anesthetic efficacy of 2% mepivacaine versus 4% articaine for inferior alveolar nerve blocks in patients withsymptomatic irreversible pulpitis in mandibular molars : A randomized clinical trial therapeutic study (MANBIP) Part 10

Anesthetic efficacy of 2% mepivacaine versus 4% articaine for inferior alveolar nerve blocks in patients with symptomatic irreversible pulpitis in mandibular molars: A randomized clinical trial (Part 3)

Anesthetic efficacy of 2% mepivacaine versus 4% articaine for inferior alveolar nerve blocks in patients with symptomatic irreversible pulpitis in mandibular molars : A randomized clinical trial therapeutic study (MANBIP) part 4

Anesthetic efficacy of 2% mepivacaine versus 4% articaine for inferior alveolar nerve blocks in patients with symptomatic irreversible pulpitis in mandibular molars: A randomized clinical trial therapeutic study (MANBIP) Part 6

Anesthetic efficacy of 2% mepivacaine versus 4% articaine for inferior alveolar nerve blocks in patients with symptomatic irreversible pulpitis in mandibular molars: A randomized clinical trial therapeutic study (MANBIP) Part 08

EFFECT OF 4% ARTICAINE INFILTRATION VERSUS 2% LIDOCAINE NERVE BLOCK AFTER PREMEDICATION BY IBUPROFEN ON ANESTHETIC EFFICACY IN ENDODONTIC TREATMENT OF ACUTE IRREVERSIBLE PULPITIS: A RANDOMIZED CLINICAL TRIAL (PART III)

ANESTHETIC EFFICACY OF 4% ARTPHARMADENT VERSUS 2% MEPECAINE-L FOR INFILTRATION ANESTHESIA IN EXTRACTION OF BADLY DECAYED LOWER FIRST PRIMARY MOLARS: A PILOT STUDY

Articaine 4% containing 1% magnesium sulphate versus articaine 4%for inferior alveolar nerve block in cases with irreversible pulpitis: randomized clinical study